Attention Deficit Hyperactivity Disorder (ADHD) Latest Advances

The Effects of Environmental Enrichment on the Behavioral Profile of an Attention-Deficit/Hyperactivity Disorder Animal Model: A Systematic Review and Meta-Analysis.

Journal: Developmental psychobiology

Published: April 15, 2026

Unmasking Potential Impacts of Parent and Coparent ADHD on Mental Health in the First Year Postpartum.

Journal: Journal of attention disorders

Published: April 15, 2026

Understanding the Relationship Between Early Elementary Children's ADHD Symptoms and Teachers' Needs Supportive Practices.

Journal: Journal of attention disorders

Published: April 15, 2026

Mental Health and Coping in Women With ADHD During the Pandemic.

Journal: Journal of attention disorders

Published: April 15, 2026

Stimulant prescription for ADHD in people with a past history of anorexia nervosa.

Journal: Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists

Published: April 13, 2026

Sex and age trends in ADHD medication use in Norway, 2020-2022: a nationwide register study.

Journal: Nordic journal of psychiatry

Published: April 10, 2026

ADHD Drug Shortage Cause Identified.

Journal: JAMA

Published: April 10, 2026

Incidence of ADHD Diagnoses on the Rise-Good or Bad News?

Journal: JAMA network open

Published: April 08, 2026

DSM-5 Changes, COVID-19, and ADHD Diagnosis Rates in Individuals Younger Than 30 Years.

Journal: JAMA network open

Published: April 08, 2026

Efficacy and Safety of Extended-Release Clonidine Hydrochloride for Attention Deficit Hyperactivity Disorder in Chinese Children and Adolescents: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Journal: Journal of child and adolescent psychopharmacology

Published: April 07, 2026

Rejection sensitivity dysphoria: a critical reflection

Journal: Tijdschrift voor psychiatrie

Published: April 07, 2026

In adults with ADHD, atomoxetine, methylphenidate, and CBT reduce symptom severity and the drugs are less tolerable vs. control at 12 wk.

Journal: Annals of internal medicine

Published: April 06, 2026

Attention Deficit Hyperactivity Disorder (ADHD) Latest Advances

Find the Latest Research About Attention Deficit Hyperactivity Disorder (ADHD)

The Effects of Environmental Enrichment on the Behavioral Profile of an Attention-Deficit/Hyperactivity Disorder Animal Model: A Systematic Review and Meta-Analysis.

The Effects of Environmental Enrichment on the Behavioral Profile of an Attention-Deficit/Hyperactivity Disorder Animal Model: A Systematic Review and Meta-Analysis.

Unmasking Potential Impacts of Parent and Coparent ADHD on Mental Health in the First Year Postpartum.

Unmasking Potential Impacts of Parent and Coparent ADHD on Mental Health in the First Year Postpartum.

Understanding the Relationship Between Early Elementary Children's ADHD Symptoms and Teachers' Needs Supportive Practices.

Understanding the Relationship Between Early Elementary Children's ADHD Symptoms and Teachers' Needs Supportive Practices.

Mental Health and Coping in Women With ADHD During the Pandemic.

Mental Health and Coping in Women With ADHD During the Pandemic.

Stimulant prescription for ADHD in people with a past history of anorexia nervosa.

Stimulant prescription for ADHD in people with a past history of anorexia nervosa.

Sex and age trends in ADHD medication use in Norway, 2020-2022: a nationwide register study.

Sex and age trends in ADHD medication use in Norway, 2020-2022: a nationwide register study.

ADHD Drug Shortage Cause Identified.

ADHD Drug Shortage Cause Identified.

Incidence of ADHD Diagnoses on the Rise-Good or Bad News?

Incidence of ADHD Diagnoses on the Rise-Good or Bad News?

DSM-5 Changes, COVID-19, and ADHD Diagnosis Rates in Individuals Younger Than 30 Years.

DSM-5 Changes, COVID-19, and ADHD Diagnosis Rates in Individuals Younger Than 30 Years.

Efficacy and Safety of Extended-Release Clonidine Hydrochloride for Attention Deficit Hyperactivity Disorder in Chinese Children and Adolescents: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Efficacy and Safety of Extended-Release Clonidine Hydrochloride for Attention Deficit Hyperactivity Disorder in Chinese Children and Adolescents: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Rejection sensitivity dysphoria: a critical reflection

Rejection sensitivity dysphoria: a critical reflection

In adults with ADHD, atomoxetine, methylphenidate, and CBT reduce symptom severity and the drugs are less tolerable vs. control at 12 wk.

In adults with ADHD, atomoxetine, methylphenidate, and CBT reduce symptom severity and the drugs are less tolerable vs. control at 12 wk.